Contribution of staphylococcus aureus coagulases and clumping factor a to abscess formation in a rabbit model of skin and soft tissue infection

PLoS ONE

Volumn 11, Issue 6, 2016, Pages

  Malachowa, Natalia ^a   Kobayashi, Scott D ^a   Porter, Adeline R ^a   Braughton, Kevin R ^a   Scott, Dana P ^a   Gardner, Donald J ^a   Missiakas, Dominique M ^b   Schneewind, Olaf ^b   DeLeo, Frank R ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CLUMPING FACTOR A; COAGULASE; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR; VON WILLEBRAND FACTOR BINDING PROTEIN; AUTACOID; CLFA PROTEIN, STAPHYLOCOCCUS AUREUS; CYTOKINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CONTROLLED STUDY; ENZYME ACTIVITY; FIBRIN DEPOSITION; HOST PATHOGEN INTERACTION; IN VITRO STUDY; NONHUMAN; PATHOGENESIS; RABBIT MODEL; SIGNAL TRANSDUCTION; SKIN ABSCESS; SKIN INFECTION; SOFT TISSUE INFECTION; STAPHYLOCOCCUS AUREUS; UPREGULATION; ABSCESS; ANIMAL; DISEASE MODEL; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; RABBITS AND HARES; STAPHYLOCOCCAL SKIN INFECTION;

ABSCESS; ANIMALS; BACTERIAL PROTEINS; COAGULASE; CYTOKINES; DISEASE MODELS, ANIMAL; INFLAMMATION MEDIATORS; RABBITS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84976555941     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0158293     Document Type: Article

References (53)

1. Moran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006; 355: 666- 74. PMID: 16914702.
2. Boucher H, Miller LG, Razonable RR. Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis. 2010; 51: S183-S97. doi: 10.1086/653519 PMID: 20731576.
3. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, et al. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med. 2005; 352: 1436-44. PMID: 15814879.
4. Landrum ML, Neumann C, Cook C, Chukwuma U, Ellis MW, Hospenthal DR, et al. Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA. 2012; 308: 50-9. doi: 10.1001/jama.2012.7139 PMID: 22760291.
5. Lowy FD. Staphylococcus aureus Infections. N Engl J Med. 1998; 339: 520-32. PMID: 9709046.
6. Kobayashi SD, Musser JM, DeLeo FR. Genomic analysis of the emergence of vancomycin-resistant Staphylococcus aureus. MBio. 2012; 3: E00170-12. doi: 10.1128/mBio.00170-12 PMID: 22736541.
7. Loeb L. The influence of certain bacteria on the coagulation of the blood. J Med Res. 1903; 10: 407-19. PMID: 19971581.
8. Bjerketorp J, Nilsson M, Ljungh Å, Flock J-I, Jacobsson K, Frykberg L. A novel von Willebrand factor binding protein expressed by Staphylococcus aureus. Microbiology. 2002; 148: 2037-44. PMID: 12101292.
9. McAdow M, DeDent AC, Emolo C, Cheng AG, Kreiswirth BN, Missiakas DM, et al. Coagulases as determinants of protective immune responses against Staphylococcus aureus. Infect Immun. 2012; 80: 3389-98. doi: 10.1128/IAI.00562-12 PMID: 22825443.
10. Friedrich R, Panizzi P, Fuentes-Prior P, Richter K, Verhamme I, Anderson PJ, et al. Staphylocoagulase is a prototype for the mechanism of cofactor-induced zymogen activation. Nature. 2003; 425: 535-9. PMID: 14523451.
11. Kroh HK, Panizzi P, Bock PE. Von Willebrand factor-binding protein is a hysteretic conformational activator of prothrombin. Proc Natl Acad Sci U S A. 2009; 106: 7786-91. doi: 10.1073/pnas.0811750106 PMID: 19416890.
12. Kobayashi SD, Malachowa N, DeLeo FR. Pathogenesis of Staphylococcus aureus abscesses. Am J Pathol. 2015; 185: 1518-27. doi: 10.1016/j.ajpath.2014.11.030 PMID: 25749135.
13. Cheng AG, McAdow M, Kim HK, Bae T, Missiakas DM, Schneewind O. Contribution of coagulases towards Staphylococcus aureus disease and protective immunity. PLoS Pathog. 2010; 6: E1001036. doi: 10.1371/journal.ppat.1001036 PMID: 20700445.
14. Vanassche T, Verhaegen J, Peetermans WE, Van Ryn J, Cheng A, Schneewind O, et al. Inhibition of staphylothrombin by dabigatran reduces Staphylococcus aureus virulence. J Thromb Haemost. 2011; 9: 2436-46. doi: 10.1111/j.1538-7836.2011.04529.x PMID: 22040101.
15. O'Brien L, Kerrigan SW, Kaw G, Hogan M, Penadés J, Litt D, et al. Multiple mechanisms for the activation of human platelet aggregation by Staphylococcus aureus: Roles for the clumping factors ClfA and ClfB, the serine- Aspartate repeat protein SdrE and protein A. Mol Microbiol. 2002; 44: 1033-44. PMID: 12010496.
16. McDevitt D, Francois P, Vaudaux P, Foster TJ. Identification of the ligand-binding domain of the surface- located fibrinogen receptor (clumping factor) of Staphylococcus aureus. Mol Microbiol. 1995; 16: 895-907. PMID: 7476187.
17. Hair PS, Echague CG, Sholl AM, Watkins JA, Geoghegan JA, Foster TJ, et al. Clumping factor A interaction with complement factor i increases C3b cleavage on the bacterial surface of Staphylococcus aureus and decreases complement-mediated phagocytosis. Infect Immun. 2010; 78: 1717-27. doi: 10. 1128/IAI.01065-09 PMID: 20100856.
18. Hair PS, Ward MD, Semmes OJ, Foster TJ, Cunnion KM. Staphylococcus aureus clumping factor A binds to complement regulator factor I and increases factor I cleavage of C3b. J Infect Dis. 2008; 198: 125-33. doi: 10.1086/588825 PMID: 18544012.
19. Higgins J, Loughman A, Van Kessel KPM, Van Strijp JAG, Foster TJ. Clumping factor A of Staphylococcus aureus inhibits phagocytosis by human polymorphonuclear leucocytes. FEMS Microbiol Lett. 2006; 258: 290-6. PMID: 16640587.
20. Baba T, Bae T, Schneewind O, Takeuchi F, Hiramatsu K. Genome sequence of Staphylococcus aureus strain Newman and comparative analysis of staphylococcal genomes: polymorphism and evolution of two major pathogenicity islands. J Bacteriol. 2008; 190: 300-10. PMID: 17951380.
21. McAdow M, Kim HK, DeDent AC, Hendrickx APA, Schneewind O, Missiakas DM. Preventing Staphylococcus aureus sepsis through the inhibition of its agglutination in blood. PLoS Pathog. 2011; 7: E1002307. doi: 10.1371/journal.ppat.1002307 PMID: 22028651.
22. Bae T, Schneewind O. Allelic replacement in Staphylococcus aureus with inducible counter-selection. Plasmid. 2006; 55: 58-63. PMID: 16051359.
23. Kobayashi SD, Malachowa N, Whitney AR, Braughton KR, Gardner DJ, Long D, et al. Comparative analysis of USA300 virulence determinants in a rabbit model of skin and soft tissue infection. J Infect Dis. 2011; 204: 937-41. doi: 10.1093/infdis/jir441 PMID: 21849291.
24. Kennedy AD, Wardenburg JB, Gardner DJ, Long D, Whitney AR, Braughton KR, et al. Targeting of alpha-hemolysin by active or passive immunization decreases severity of USA300 skin infection in a mouse model. J Infect Dis. 2010; 202: 1050-8. doi: 10.1086/656043 PMID: 20726702.
25. Carson FL., Hladik C. Histotechnology: A self-instructional text. 3rd ed. American Society for Clinical Pathology Press; 2009.
26. Cheng AG, Kim HK, Burts ML, Krausz T, Schneewind O, Missiakas DM. Genetic requirements for Staphylococcus aureus abscess formation and persistence in host tissues. FASEB J. 2009; 23: 3393- 404. doi: 10.1096/fj.09-135467 PMID: 19525403.
27. Kwiecinski J, Jin T, Josefsson E. Surface proteins of Staphylococcus aureus play an important role in experimental skin infection. APMIS. 2014; 122: 1240-50. doi: 10.1111/apm.12295 PMID: 25051890.
28. Loof TG, Goldmann O, Naudin C, Mörgelin M, Neumann Y, Pils MC, et al. Staphylococcus aureusinduced clotting of plasma is an immune evasion mechanism for persistence within the fibrin network. Microbiology. 2015; 161: 621-7. doi: 10.1099/mic.0.000019 PMID: 25533444.
29. Malachowa N, Kobayashi SD, Sturdevant DE, Scott DP, DeLeo FR. Insights into the Staphylococcus aureus-host interface: global changes in host and pathogen gene expression in a rabbit skin infection model. PLoS ONE. 2015; 10: E0117713. doi: 10.1371/journal.pone.0117713 PMID: 25719526.
30. Miller LS, Cho JS. Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol. 2011; 11: 505-18. doi: 10.1038/nri3010 PMID: 21720387.
31. Rogers DE. Studies on bacteriemia: I. Mechanisms relating to the persistence of bacteriemia in rabbits following the intravenous injection of staphylococci. J Exp Med. 1956; 103: 713-42. PMID: 13319588.
32. Rogers DE, Melly MA. Studies on bacteriemia: II. Further observations on the granulocytopenia induced by the intravenous injection of staphylococci. J Exp Med. 1957; 105: 99-112. PMID: 13406171.
33. Cheung AL, Eberhardt KJ, Chung E, Yeaman MR, Sullam PM, Ramos M, et al. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis. J Clin Invest. 1994; 94: 1815-22. PMID: 7962526.
34. Lin Y-C, Anderson MJ, Kohler PL, Strandberg KL, Olson ME, Horswill AR, et al. Proinflammatory exoprotein characterization of toxic shock syndrome Staphylococcus aureus. Biochemistry. 2011; 50: 7157-67. doi: 10.1021/bi200435n PMID: 21749039.
35. Spaulding AR, Lin Y-C, Merriman JA, Brosnahan AJ, Peterson ML, Schlievert PM. Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses. Vaccine. 2012; 30: 5099- 109. doi: 10.1016/j.vaccine.2012.05.067 PMID: 22691432.
36. Strandberg KL, Rotschafer JH, Vetter SM, Buonpane RA, Kranz DM, Schlievert PM. Staphylococcal superantigens cause lethal pulmonary disease in rabbits. J Infect Dis. 2010; 202: 1690-7. doi: 10.1086/657156 PMID: 20979456.
37. Croisier-Bertin D, Piroth L, Charles P-E, Larribeau A, Biek D, Ge Y, et al. Ceftaroline versus ceftriaxone in a highly penicillin-resistant pneumococcal pneumonia rabbit model using simulated human dosing. Antimicrob Agents Chemother. 2011; 55: 3557-63. doi: 10.1128/AAC.01773-09 PMID: 21576444.
38. Bernheimer AW. Staphylococcal alpha toxin. Ann N Y Acad Sci. 1965; 128: 112-23. PMID: 5216753 39.
39. Wiseman GM. The hemolysins of Staphylococcus aureus. Bacteriol Rev. 1975; 39: 317-44. PMID: 1108866.
40. Cribier B, Prévost G, Couppie P, Finck-Barbançon V, Grosshans E, Piémont Y. Staphylococcus aureus leukocidin: A new virulence factor in cutaneous infections? An epidemiological and experimental study. Dermatology. 1992; 185:175-80. PMID: 1446082.
41. Neves F, Abrantes J, Almeida T, de Matos AL, Costa PP, Esteves PJ. Genetic characterization of interleukins (IL-1α, IL-1β, IL-2, IL-4, IL-8, IL-10, IL-12A, IL-12B, IL-15 and IL-18) with relevant biological roles in lagomorphs. Innate Immun. 2015; 21: 787-801. doi: 10.1177/1753425915606209 PMID: 26395994.
42. Mestas J, Hughes CCW. Of mice and not men: Differences between mouse and human immunology. J Immunol. 2004; 172: 2731-8. PMID: 14978070.
43. Kielian T, Bearden ED, Baldwin AC, Esen N. IL-1 and TNF-α play a pivotal role in the host immune response in a mouse model of Staphylococcus aureus-induced experimental brain abscess. J Neuropathol Exp Neurol. 2004; 63: 381-96. PMID: 15099027.
44. Holley MM, Kielian T. Th1 and Th17 cells regulate innate immune responses and bacterial clearance during central nervous system infection. J Immunol. 2012; 188: 1360-70. doi: 10.4049/jimmunol. 1101660 PMID: 22190181.
45. Cho JS, Guo Y, Ramos RI, Hebroni F, Plaisier SB, Xuan C, et al. Neutrophil-derived IL-1β is sufficient for abscess formation in immunity against Staphylococcus aureus in mice. PLoS Pathog. 2012; 8: E1003047. doi: 10.1371/journal.ppat.1003047 PMID: 23209417.
46. Chan LC, Chaili S, Filler SG, Barr K, Wang H, Kupferwasser D, et al. Nonredundant roles of interleukin- 17A (IL-17A) and IL-22 in murine host defense against cutaneous and hematogenous infection due to methicillin-resistant Staphylococcus aureus. Infect Immun. 2015; 83: 4427-37. doi: 10.1128/IAI.01061- 15 PMID: 26351278.
47. De Navasquez S. Experimental pyelonephritis in the rabbit produced by staphylococcal infection. J Pathol Bacteriol. 1950; 62: 429-36. PMID: 14784907.
48. Freedman LR. Experimental pyelonephritis VI. observations on susceptibility of the rabbit kidney to infection by a virulent strain of Staphylococcus aureus. Yale J Biol Med. 1960; 32: 272-9. PMID: 13824718.
49. Miller LS, Pietras EM, Uricchio LH, Hirano K, Rao S, Lin H, et al. Inflammasome-mediated production of IL-1β is required for neutrophil recruitment against Staphylococcus aureus in vivo. J Immunol. 2007; 179: 6933-42. PMID: 17982084.
50. Krishna S, Miller LS. Host-pathogen interactions between the skin and Staphylococcus aureus. Curr Opin Microbiol. 2012; 15: 28-35. doi: 10.1016/j.mib.2011.11.003 PMID: 22137885.
51. Gautam N, Maria Olofsson A, Herwald H, Iversen LF, Lundgren-Akerlund E, Hedqvist P, et al. Heparinbinding protein (HBP/CAP37): A missing link in neutrophil-evoked alteration of vascular permeability. Nat Med. 2001; 7: 1123-7. PMID: 11590435.
52. Edens HA, Parkos CA. Neutrophil transendothelial migration and alteration in vascular permeability: focus on neutrophil-derived azurocidin. Curr Opin Hematol. 2003; 10: 25-30. PMID: 12483108 53.
53. Weisel JW, Fibrinogen and fibrin. In: Fibrous Proteins: Coiled-Coils, Collagen and Elastomers. Adv Protein Chem. 2005; 70: 247-99. PMID: 15837518.